Cardiosense raises Series A to use AI to detect heart disease
Cardiosense raises Series A to use AI to detect heart disease
Cardiosense raises Series A to use AI to detect heart disease Alex Zorn
Cardiosense Inc. announced this week that it raised $15.1 million in Series A funding. The round was led by Broadview Ventures and Hatteras Venture Partners, with participation from Laerdal Million Lives Fund, OSF Ventures, UnityPoint Health Ventures and Portal Innovations. The Chicago-based digital health company will use the capital to expand its team, accelerate product development and fund a heart-failure study. The company also hopes to get regulatory clearance for its CardioTag product,… 1670620090